Same-day colonoscopy preparation with Senna alkaloids and bisacodyl tablets: A pilot study

Table 1 Details of pre-procedural data

Characteristic	n
Gender
Male	35 (46.7%)
Female	40 (53.3%)
Comorbid diseases
None	44 (58.7%)
Diabetes mellitus	2 (2.7%)
Hypertension	15 (20.0%)
Diabetes mellitus + hypertension	7 (9.3%)
Depression	2 (2.7%)
Neurologic disease	2 (2.7%)
Others (dermatologic/urologic/gynecologic)	3 (4.0%)
Colonoscopy indication
Constipation	13 (17.3%)
Abdominal pain	12 (16.0%)
Screening1	24 (32.0%)
Rectal bleeding	12 (16.0%)
Chronic diarrhea	8 (10.7%)
Postoperative control	6 (8.0%)
Complete lack of compliance with the bowel preparation protocol	5 (6.7%)

¹As there is no screening program in Turkey, vague indications for endoscopy were abdominal pain and bloating without any other symptoms, and patients > 50 years of age.

Table 2 Details of during-procedural data

Characteristic	Value
Duration of colonoscopy (min)	16.12 ± 6.51
Withdrawal time (min)	8.89 ± 4.07
Cecal intubation rate (n = 64)	61 (93.8%)
Premature withdrawal due to insufficient bowel preparation	7 (9.3%)
Premature withdrawal due to insufficient bowel preparation in protocol patients	2 (2.7%)
Polyp detection rate
Overall	30 (40.0%)
Male (n = 35)	18 (51.4%)
Female (n = 40)	12 (30.0%)
Boston bowel preparation scores
Overall	7.38 ± 1.81
Right colon	2.34 ± 0.89
Transvers colon	2.52 ± 0.67
Left colon	2.52 ± 0.63
Presence of foam and clear liquid
Foam	1 (1.3%)
Clear liquid	32 (42.7%)
Foam + clear liquid	20 (26.7%)
Sedation dose
No sedation	1 (1.3%)
Mild sedation	6 (8.0%)
Moderate sedation	59 (78.7%)
Deep sedation	9 (12.0%)

Values are expressed as mean ± SD or n (%).